Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BK-SE36 malaria vaccine safety and immunogenicity study in African children in Burkina Faso
PACTR201411000934120Phase 0Unknown
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 0 trial of BK-SE36, sponsored by Nobelpharma Co., Ltd. Status: unknown.
02
Drugs
BK-SE36
Beyond the preview
Go deeper on PACTR201411000934120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201411000934120.